Fundraising FoxE9 Genomics
1 known investors
Find your way into E9 Genomics
Sign up to find every way you can get introduced to E9 Genomics
- Your email: who you already know at E9 Genomics, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the E9 Genomics team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
E9 Genomics builds Urchin, an agentic biological search and reasoning platform that autonomously searches, integrates, and reasons over public and private biological data to help biopharma teams find non-obvious, high-value opportunities. It serves drug discovery teams for use cases such as indication selection, drug repurposing, and target prioritization, and currently operates as a collaborative service deploying Urchin on client projects.
Investors · 1
Frequently asked questions
- What does E9 Genomics do?
- E9 Genomics builds Urchin, an agentic biological search and reasoning platform that autonomously searches, integrates, and reasons over public and private biological data to help biopharma teams find non-obvious, high-value opportunities. It serves drug discovery teams for use cases such as indication selection, drug repurposing, and target prioritization, and currently operates as a collaborative service deploying Urchin on client projects.
- Who are E9 Genomics's investors?
- E9 Genomics's investors include Mute Ventures.